Member Info for DugWalker

Appears to have started with the rotor running in reverse.

Ignore the baselessly hopeful. The fundamentals and management here are as bad as it gets.

Why the question mark?

If you are clueless don't try and misleading.

Sell.

Aye 2p "on the pump" or 0.6 if another II decides to get out whilst they can.

It's stopped raining here, so that's good, but huge is a bit of a stretch unless you're expecting a sudden gift of insight.

Except the market doesn't seem to agree Laura as is witnessed by the continued slide of the SP.

Reality is Burrows has been econo.ical with the truth on several key aspects not least of which was the Transform project.

As I said who are these distributors going to distribute to. Nobody wants these tests and they only have months before the money runs out.

If if if....

Icecool.

They have a 5 fold increase in the PSE sales team for a variety of reasons.

1. Their peer to peer sales strategy for CiRT was hopelessly misguided and an abject failure.

2. They have no real understanding of cost cutting and are ploughing on with 3 labs, and a oversized and underperforming sales and marketing team, preferring to switch the entire CiRT team to PSE than make some redundant. (Why not do this restructure months ago since it has been obvious for a very long time that the lack of validation was a major block on sales of CiRT)?

3. The entire collective of sales and marketing VP's and directors are Burrows' old chums and colleagues. They need an apparent justification to keep the wheels of the gravy train in motion.

PI would it not be a more accurate reflection of the facts to suggest that when Burrows wins its at the expense of shareholders?

404.

Sorry but you are looking at the accounts for PXEN who trade as an investment company. Their revenues are vested in their subsidiaries (Tarba in Spain and PVE in Italy). They have no debts and are cash generative.

As suggested DYOR.

Be very cautious 'rolling a dice' here. They can't sell their 'flagship products' and none of their products (flagship or pipeline are validated. What difference does potential distribution deal make when there is nobody to distribute to? They need cash but have nothing to sell so it's a placing or admin.

If folks want a low risk option to recoup losses take a look at PXEN.

https://youtu.be/6usUQKkJhew

No debt.

Cash generative.

Growing revenues (soon to exceed current mcap)

Significant pipeline of positive newsflow.

Partnership with major industry player who have recently taken a 10% share in PXEN.

DYOR.

We're you given your username due to a propensity to burn your fingers?

None of the tests are properly validated at scale. Doctors making potential life or death decisions won't make them based on unvalidated tests. That has been obvious since Burrows spoke about doctors at one of his workshops offering blunt and frank.feedback. For me, the final nail in the coffin was his comical attempt to appear knowledgeable about the Transform trial by reading Prostate Cancer UK's press release from a crib sheet before announcing he was employing a lobbyist to push for participation. This breathtaking ignorance led to me selling all but a token shareholding. The man is incompetent and woefully iĺl informed. The worst CEO it has been my misfortune to encounter.

Wow. 2 million sold in rounded volumes in less than 5 minutes Looks like someone is keen to be out.

Had hoped the RNS was announcing the departure of Burrows and a few of his cronies. Better luck next time?

The share price is down 66% in less than 2 days and they are selling, not buying. It's certainly not a vote of confidence.

Institutional investor trimming holding.

Significant rounded volume sales coming in.

Where is our Chhairman and why isn't he demanding resignations?